Motility disorders in intestinal failure

Clinical Management of Intestinal Failure

Volumn , Issue , 2011, Pages 31-46

  Rodriguez, Leonel ^a   Nurko, Samuel ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85059406945     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (89)

1. Szurszewski JH. A migrating electric complex of canine small intestine. Am J Physiol 1969;217:1757-63
2. Vantrappen G, Janssens J, Hellemans J, and Ghoos Y. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest 1977;59:1158-66
3. Uc A, Hoon A, Di Lorenzo C, and Hyman PE. Antroduodenal manometry in children with no upper gastrointestinal symptoms. Scand J Gastroenterol 1997;32:681-5
4. Di Lorenzo C, Lucanto C, Flores AF, Idries S, and Hyman PE. Effect of sequential erythromycin and octreotide on antroduodenal manometry. J Pediatr Gastroenterol Nutr 1999;29:293-6
5. Remington M, Malagelada JR, Zinsmeister A, and Fleming CR. Abnormalities in gastrointestinal motor activity in patients with short bowels: Effect of a synthetic opiate. Gastroenterology 1983;85:629-36
6. Nightingale JM, Kamm MA, van der Sijp JR, Ghatei MA, Bloom SR, and Lennard-Jones JE. Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying. Gut 1996;39:267-72
7. Nightingale JM, Kamm MA, van der Sijp JR, Morris GP, Walker ER, Mather SJ, Britton KE, and Lennard-Jones JE. Disturbed gastric emptying in the short bowel syndrome. Evidence for a 'colonic brake' Gut 1993;34:1171-6
8. Georgeson KE and Breaux CW, Jr. Outcome and intestinal adaptation in neonatal short-bowel syndrome. J Pediatr Surg 1992;27:344-8; discussion 348-50
9. Spencer AU, Neaga A, West B, Safran J, Brown P, Btaiche I, Kuzma-O'Reilly B, and Teitelbaum DR. Pediatric short bowel syndrome: Redefining predictors of success. Ann Surg 2005;242:403-9; discussion 409-12
10. Ladd AP, Rescorla FJ, West KW, Scherer LR, 3rd, Engum SA, and Grosfeld JL. Long-term follow-up after bowel resection for necrotizing enterocolitis: Factors affecting outcome. J Pediatr Surg 1998;33:967-72
11. Quigley EM and Thompson JS. The motor response to intestinal resection: Motor activity in the canine small intestine following distal resection. Gastroenterology 1993;105:791-8
12. Weber TR and Powell MA. Early improvement in intestinal function after isoperistaltic bowel lengthening. J Pediatr Surg 1996;31:61-3; discussion 63-4
13. Kaji T, Tanaka H, Wallace LE, Kravarusic D, Holst J, and Sigalet DL. Nutritional effects of the serial transverse enteroplasty procedure in experimental short bowel syndrome. J Pediatr Surg 2009;44:1552-9
14. Modi BP, Ching YA, Langer M, Donovan K, Fauza DO, Kim RB, Jaksic T, and Nurko S. Preservation of intestinal motility after the serial transverse enteroplasty procedure in a large animal model of short bowel syndrome. J Pediatr Surg 2009;44:229-35; discussion 235
15. Cavell B. Gastric emptying in infants fed human milk or infant formula. Acta Paediatr Scand 1981;70:639-41
16. Ewer AK, Durbin GM, Morgan ME, and Booth IW. Gastric emptying in preterm infants. Arch Dis Child Fetal Neonatal Ed 1994;71:F24-7
17. Siegel M, Lebenthal E, and Krantz B. Effect of caloric density on gastric emptying in premature infants. J Pediatr 1984;104:118-22
18. Shimoyama Y, Kusano M, Kawamura O, Zai H, Kuribayashi S, Higuchi T, Nagoshi A, Maeda M, and Mon M. High-viscosity liquid meal accelerates gastric emptying. Neurogastroenterol Motil 2007;19:879-86
19. Tomomasa T, Hyman PE, Itoh K, Hsu JY, Koisumi T, Itoh Z, and Kurome T. Gastroduodenal motility in neonates: Response to human milk compared with cow's milk formula. Pediatrics 1987;80:434-8
20. Farthing MJ. Octreotide in dumping and short bowel syndromes. Digestion 1993;54(Suppl 1):47-52
21. Ladefoged K, Christensen KC, Hegnhoj J, and Jarnum S. Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome. Gut 1989;30:943-9
22. Nehra V, Camilleri M, Burton D, Oenning L, and Kelly DG. An open trial of octreotide long-acting release in the management of short bowel syndrome. Am J Gastroenterol 2001;96:1494-8
23. Ohlbaum P, Galperine RI, Demarquez JL, Vergnes P, and Martin C. Use of a long-acting somatostatin analogue (SMS 201-995) in controlling a significant ileal output in a 5-year-old child. J Pediatr Gastroenterol Nutr 1987;6:466-70
24. Sukhotnik I, Khateeb K, Krausz MM, Sabo E, Siplovich L, Coran AG, and Shiloni E. Sandostatin impairs postresection intestinal adaptation in a rat model of short bowel syndrome. Dig Dis Sci 2002;47:2095-102
25. Vanderhoof JA and Kollman KA. Lack of inhibitory effect of octreotide on intestinal adaptation in short bowel syndrome in the rat. J Pediatr Gastroenterol Nutr 1998;26:241-4
26. Raphael B, Nurko S, Jiang H, Hart K, Jaksic T, and Duggan C. Cisapride for enteral intolerance in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr 2009
27. Rudolph CD, Hyman PE, Altschuler SM, Christense J, Colletti RB, Cuchiara S, Di Lorenzo C et al. Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: Report of consensus workshop. J Pediatr Gastroenterol Nutr 1997;24:102-12
28. Vargas JH, Sachs P, and Ament ME. Chronic intestinal pseudo-obstruction syndrome in pediatrics. Results of a national survey by members of the North American Society of Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 1988;7:323-32
29. Mousa H, Hyman PE, Cocjin J, Flores AF, and Di Lorenzo C. Long-term outcome of congenital intestinal pseudoobstruction. Dig Dis Sci 2002;47:2298-305
30. Heneyke S, Smith VV, Spitz L, and Milla PJ. Chronic intestinal pseudo-obstruction: Treatment and long term follow up of 44 patients. Arch Dis Child 1999;81:21-7
31. Martinez Martinez L, Lopez Santamaria M, Prieto Bozano G, Molina Arias M, Jimenez Alvarez C, and Tovar Larrucea JA. Diagnosis and therapeutic options in chronic idiopathic intestinal pseudo-obstruction: Review of 16 cases. Cir Pediatr 1999;12:71-4
32. Goulet O, Jobert-Giraud A, Michel JL, Jaubert F, Lortat-Jacob S, Colomb V, Cuenod-Jabri B et al. Chronic intestinal pseudo-obstruction syndrome in pediatric patients. Eur J Pediatr Surg 1999;9:83-9
33. Faure C, Goulet O, Ategbo S, Breton A, Tounian P, Ginies JL, Roquelaure B et al. Chronic intestinal pseudoobstruction syndrome: Clinical analysis, outcome, and prognosis in 105 children. French-Speaking Group of Pediatric Gastroenterology. Dig Dis Sci 1999;44:953-9
34. Fang X, Ke M, and Liu X. Clinical characteristics and diagnosis of chronic intestinal pseudo-obstruction. Zhonghua Nei Ke Za Zhi 2001;40:666-9
35. Almeida PS and Penna FJ. Chronic intestinal pseudo-obstruction in children-Report of seven cases. J Pediatr (Rio J) 2000;76:453-7
36. Lapointe SP, Rivet C, Goulet O, Fekete CN, and Lortat-Jacob S. Urological manifestations associated with chronic intestinal pseudo-obstructions in children. J Urol 2002;168:1768-70
37. Feldstein AE, Miller SM, El-Youssef M, Rodeberg D, Lindor NM, Burgart U, Szurszewski JH, and Farrugia G. Chronic intestinal pseudoobstruction associated with altered interstitial cells of cajal networks. J Pediatr Gastroenterol Nutr 2003;36:492-7
38. Kenny SE, Vanderwinden JM, Rintala RJ, Connell MG, Lloyd DA, Vanderhaegen JJ, and De Laet MH. Delayed maturation of the interstitial cells of Cajal: A new diagnosis for transient neonatal pseudoobstruction. Report of two cases. J Pediatr Surg 1998;33:94-8
39. Bosman C, Devito R, Fusilli S, and Boldrini R. A new hypothesis on the pathogenesis of intestinal pseudo-obstruction by intestinal neuronal dysplasia (IND). Pathol Res Pract 2001;197:789-96
40. De Giorgio R and Camilleri M. Human enteric neuropathies: Morphology and molecular pathology. Neurogastroenterol Motil 2004;16:515-31
41. Darvishian F and Basham K. Familial visceral myopathy with carcinoma of unknown primary. Ann Clin Lab Sci 2002;32:93-7
42. Smith VV and Milla PJ. Histological phenotypes of enteric smooth muscle disease causing functional intestinal obstruction in childhood. Histopathology 1997;31:112-22
43. Schuffler MD and Pope CE, 2nd. Esophageal motor dysfunction in idiopathic intestinal pseudoobstruction. Gastroenterology 1976;70:677-82
44. Boige N, Faure C, Cargill G, Cordeiro-Ferreira G, Viarme F, Cezard JP, and Nacano J. Manometrical evaluation in visceral neuropathies in children. J Pediatr Gastroenterol Nutr 1994;19:71-7
45. Hyman PE, McDiarmid SV, Napolitano J, Abrams CE, and Tomomasa T. Antroduodenal motility in children with chronic intestinal pseudo-obstruction. J Pediatr 1988;112:899-905
46. Watanabe Y, Ito T, Ando H, Seo T, and Nimura Y. Manometric evaluation of gastrointestinal motility in children with chronic intestinal pseudo-obstruction syndrome. J Pediatr Surg 1996;31:233-8
47. Bracci F, Iacobelli BD, Papadatou B, Ferretti F, Lucchetti MC, Cianchi D, Francalanci P, and Pnticelli A. Role of electrogastrography in detecting motility disorders in children affected by chronic intestinal pseudo-obstruction and Crohn's disease. Eur J Pediatr Surg 2003;13:31-4
48. Devane SP, Ravelli AM, Bisset WM, Smith VV, Lake BD, and Milla PJ. Gastric antral dysrhythmias in children with chronic idiopathic intestinal pseudoobstruction. Gut 1992;33:1477-81
49. Debinski HS, Ahmed S, Milla PJ, and Kamm MA. Electrogastrography in chronic intestinal pseudoobstruction. Dig Dis Sci 1996;41:1292-7
50. Cucchiara S, Borrelli O, Salvia G, Lula VD, Fecarotta S, Gaudiello G, Boccia G, and Annese V. A normal gastrointestinal motility excludes chronic intestinal pseudoobstruction in children. Dig Dis Sci 2000;45:258-64
51. Tomomasa T, DiLorenzo C, Morikawa A, Uc A, Hyman PE. Analysis of fasting antroduodenal manometry in children. Dig Dis Sci 1996;41:2195-203
52. Hyman PE, Napolitano JA, Diego A, Patel S, Flores AF, Grill BB, Reddy SN, Garvey TQ 3rd, and Tomomasa T. Antroduodenal manometry in the evaluation of chronic functional gastrointestinal symptoms. Pediatrics 1990;86:39-44
53. Fell JM, Smith VV, and Milla PJ. Infantile chronic idiopathic intestinal pseudo-obstruction: The role of small intestinal manometry as a diagnostic tool and prognostic indicator. Gut 1996;39:306-11
54. Di Lorenzo C, Flores AF, Buie T, and Hyman PE. Intestinal motility and jejunal feeding in children with chronic intestinal pseudo-obstruction. Gastroenterology 1995;108:1379-85
55. Frank JW, Sarr MG, and Camilleri M. Use of gastroduodenal manometry to differentiate mechanical and functional intestinal obstruction: An analysis of clinical outcome. Am J Gastroenterol 1994;89:339-44
56. Loftus EV, Jr., Farrugia G, Donohue JH, and Camilleri M. Duodenal obstruction: Diagnosis by gastroduodenal manometry. Mayo Clin Proc 1997;72:130-2
57. Stanghellini V, Camilleri M, and Malagelada JR. Chronic idiopathic intestinal pseudo-obstruction: Clinical and intestinal manometric findings. Gut 1987;28:5-12
58. Di Lorenzo C, Flores AF, Reddy SN, Snape WJ, Jr., Bazzocchi G, and Hyman PE. Colonic manometry in children with chronic intestinal pseudo-obstruction. Gut 1993;34:803-7
59. Di Lorenzo C, Flores AF, Tomomasa T, and Hyman PE. Effect of erythromycin on antroduodenal motility in children with chronic functional gastrointestinal symptoms. Dig Dis Sci 1994;39:1399-404
60. Quigley EM. Chronic Intestinal Pseudo-obstruction. Curr Treat Options Gastroenterol 1999; 2:239-250
61. Verne GN, Eaker EY, Hardy E, and Sninsky CA. Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction. Dig Dis Sci 1995;40:1892-901
62. Lux G, Katschinski M, Ludwig S, Lederer P, Ellermann A, and Domschke W. The effect of cisapride and metoclopramide on human digestive and interdigestive antroduodenal motility. Scand J Gastroenterol 1994;29:1105-10
63. Sorhaug S, Steinshamn SL, and Waldum HL. Octreotide treatment for paraneoplastic intestinal pseudo-obstruction complicating SCLC. Lung Cancer 2005;48:137-40
64. Lecomte T, Cavicchi M, and Delchier JC. Small bowel pseudo-obstruction revealing an early scleroderma. Long-term efficacy of octreotide and erythromycin. Gastroenterol Clin Biol 2000;24:361-3
65. Di Lorenzo C, Lucanto C, Flores AF, Idries S, and Hyman PE. Effect of octreotide on gastrointestinal motility in children with functional gastrointestinal symptoms. J Pediatr Gastroenterol Nutr 1998;27:508-12
66. Rodriguez LFA. Daily intravenous octreotide promotes enteral feeding tolerance in children with chronic intestinal pseudo-obstruction. J Pediatr Gastroenterol Nutr 2009;49(1):E50
67. Miller LS, Szych GA, Kantor SB, Bromer MQ, Knight LC, Maurer AH, Fisher RS, and Parkman HP. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol 2002;97:1653-60
68. Woodward MN and Spicer RD. Intrapyloric botulinum toxin injection improves gastric emptying. J Pediatr Gastroenterol Nutr 2003;37:201-2
69. Muniz-Crim A, Rodriguez L, and Flores A. Effect of pyloric injection of botulinum toxin in children with gastroparesis. J Pediatr Gastroenterol Nutr 2005;41:521
70. Llop Talaveron J, Juvany Roig R, Tubau Molas M, Virgili Casas N, Pita Merce A, and Jodar Masanes R. Quality of the home parenteral nutrition program: 14 years of experience at a general university hospital. Nutr Hosp 2000;15:64-70
71. Vantini I, Benini L, Bonfante F, Talamini G, Semenini C, Chiarioni G, Maragnolli O, Benini F, and Capra F. Survival rate and prognostic factors in patients with intestinal failure. Dig Liver Dis 2004;36:46-55
72. Kluck P, Tibboel D, van der Kamp AW, and Molenaar JC. The effect of fetal urine on the development of the bowel in gastroschisis. J Pediatr Surg 1983;18:47-50
73. Langer JC, Longaker MT, Crombleholme TM, Bond SJ, Finkbeiner WE, Rudolph CA, Verrier ED, and Harrison MR. Etiology of intestinal damage in gastroschisis. I: Effects of amniotic fluid exposure and bowel constriction in a fetal lamb model. J Pediatr Surg 1989;24:992-7
74. Oyachi N, Lakshmanan J, Ross MG, and Atkinson JB. Fetal gastrointestinal motility in a rabbit model of gastroschisis. J Pediatr Surg 2004;39:366-70
75. Vargun R, Aktug T, Heper A, and Bingol-Kologlu M. Effects of intrauterine treatment on interstitial cells of Cajal in gastroschisis. J Pediatr Surg 2007;42:783-7
76. Vannucchi MG, Midrio P, Zardo C, and Faussone-Pellegrini MS. Neurofilament formation and synaptic activity are delayed in the myenteric neurons of the rat fetus with gastroschisis. Neurosci Lett 2004;364:81-5
77. Bealer JF, Graf J, Bruch SW, Adzick NS, and Harrison MR. Gastroschisis increases small bowel nitric oxide synthase activity. J Pediatr Surg 1996;31:1043-5; discussion 1045-6
78. Tibboel D, Kluck P, van der Kamp AW, Vermey-Keers C, and Molenaar JC. The development of the characteristic anomalies found in gastroschisis-Experimental and clinical data. Z Kinderchir 1985;40:355-60
79. Jadcherla SR, Gupta A, Stoner E, Fernandez S, Caniano D, and Rudolph CD. Neuromotor markers of esophageal motility in feeding intolerant infants with gastroschisis. J Pediatr Gastroenterol Nutr 2008;47:158-64
80. Cheng G, Langham MR, Jr., Sninsky CA, Talbert JL, and Hocking MP. Gastrointestinal myoelectric activity in a child with gastroschisis and ileal atresia. J Pediatr Surg 1997;32:923-7
81. Curry JI, Lander AD, and Stringer MD. A multicenter, randomized, double-blind, placebo-controlled trial of the prokinetic agent erythromycin in the postoperative recovery of infants with gastroschisis. J Pediatr Surg 2004;39:565-9
82. Langer JC and Bramlett G. Effect of prokinetic agents on ileal contractility in a rabbit model of gastroschisis. J Pediatr Surg 1997;32:605-8
83. Johnson CP, Sarna SK, Zhu YR, Buchrnann E, Bonham L, Telford GL, Roza AM, and Adams MB. Effects of intestinal transplantation on postprandial motility and regulation of intestinal transit. Surgery 2001;129:6-14
84. Matsuura T, Masumoto K, Ieiri S, Nakatsuji T, Akiyoshi J, Nishimoto Y, Takahashi Y, Hayashida M, and Taguchi T. Morphological and physiological changes of interstitial cells of Cajal after small bowel transplantation in rats. Transpl Int 2007;20:616-24
85. Matsuura T, Taguchi T, Hayashida M, Ogita K, Takada N, Nishimoto Y, Taguchi S et al. Relationship between real-time monitoring of the graft motility and mucosal histology in swine intestinal transplantation. Transpl Proc 2006;38:1851-2
86. Matsuura T, Taguchi T, Hayashida M, Ogita K, Takada N, Nishimoto Y, Taguchi S et al. The influence of rejection on graft motility after intestinal transplantation in swine: The possibility of using this method for the real-time monitoring of acute cellular rejection. J Pediatr Surg 2007;42:1377-85
87. Nakada K, Ikoma A, Suzuki T, Reynolds JC, Campbell WL, Todo S, and Starzl E. Amelioration of intestinal dysmotility and stasis by octreotide early after small-bowel autotransplantation in dogs. Am J Surg 1995;169:294-9
88. Mousa H, Bueno J, Griffiths J, Kocoshis S, Todo S, Reyes J, and Di Lorenzo C. Intestinal motility after small bowel transplantation. Transpl Proc 1998;30:2535-6
89. Nurko S. Gastrointestinal manometry, methodology, and indications. In Kleinman RE, Sanderson IR, Goulet O, Sherman P, Miele-Vergani G, Shneider BL (eds) Pediatric Gastrointestinal Disease, 5th edn. Philadelphia, PA; B.C. Decker Inc., 2008, pp. 1375-91